These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 14724226)
1. Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. Banks WA; During MJ; Niehoff ML J Pharmacol Exp Ther; 2004 May; 309(2):469-75. PubMed ID: 14724226 [TBL] [Abstract][Full Text] [Related]
2. Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration. Ducharme N; Banks WA; Morley JE; Robinson SM; Niehoff ML; Mattern C; Farr SA Eur J Pharmacol; 2010 Sep; 641(2-3):128-34. PubMed ID: 20570588 [TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal tracking of gold nanorods after intranasal administration for brain targeting. Han S; Wang JT; Yavuz E; Zam A; Rouatbi N; Utami RN; Liam-Or R; Griffiths A; Dickson W; Sosabowski J; Al-Jamal KT J Control Release; 2023 May; 357():606-619. PubMed ID: 37061195 [TBL] [Abstract][Full Text] [Related]
4. Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration. Hatakawa Y; Tanaka A; Furubayashi T; Nakamura R; Konishi M; Akizawa T; Sakane T Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683967 [TBL] [Abstract][Full Text] [Related]
5. Utility of a Novel Micro-Spraying Device for Intranasal Administration of Drug Solutions to Mice. Suzuki N; Tanigawa H; Nagatomo T; Miyagishi H; Kanazawa T; Suzuki T; Kosuge Y Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004533 [TBL] [Abstract][Full Text] [Related]
6. Rapid and Widespread Distribution of Intranasal Small Extracellular Vesicles Derived from Mesenchymal Stem Cells throughout the Brain Potentially via the Perivascular Pathway. Shen W; You T; Xu W; Xie Y; Wang Y; Cui M Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004556 [TBL] [Abstract][Full Text] [Related]
7. GLP-1 derivatives with functional sequences transit and migrate through trigeminal neurons. Akita T; Shimamura M; Tezuka A; Takagi M; Yamashita C Eur J Pharm Biopharm; 2024 Feb; 195():114176. PubMed ID: 38185192 [TBL] [Abstract][Full Text] [Related]
8. Intranasal insulin's effects on the sense of smell. Sienkiewicz-Oleszkiewicz B; Oleszkiewicz A; Bock MA; Hummel T Rhinology; 2023 Oct; 61(5):404-411. PubMed ID: 37453136 [TBL] [Abstract][Full Text] [Related]
9. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Thorne RG; Pronk GJ; Padmanabhan V; Frey WH Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337 [TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of Exendin-4 antagonizes Aβ31-35-induced disruption of circadian rhythm and impairment of learning and memory. Wang X; Wang L; Xu Y; Yu Q; Li L; Guo Y Aging Clin Exp Res; 2016 Dec; 28(6):1259-1266. PubMed ID: 26920423 [TBL] [Abstract][Full Text] [Related]
11. Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice. Zhang H; Meng J; Zhou S; Liu Y; Qu D; Wang L; Li X; Wang N; Luo X; Ma X AAPS J; 2016 Mar; 18(2):385-94. PubMed ID: 26689204 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity. Lockie SH J Neuroendocrinol; 2013 Jul; 25(7):597-604. PubMed ID: 23590331 [TBL] [Abstract][Full Text] [Related]
13. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023 [TBL] [Abstract][Full Text] [Related]
14. Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders. Patharapankal EJ; Ajiboye AL; Mattern C; Trivedi V Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258077 [TBL] [Abstract][Full Text] [Related]
15. Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives. Yue W; Shen J Pharmaceuticals (Basel); 2023 May; 16(6):. PubMed ID: 37375758 [TBL] [Abstract][Full Text] [Related]
16. Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs. De Martini LB; Sulmona C; Brambilla L; Rossi D Cells; 2023 Jun; 12(12):. PubMed ID: 37371113 [TBL] [Abstract][Full Text] [Related]
17. Intranasal Fentanyl for Acute Pain Management in Children, Adults and Elderly Patients in the Prehospital Emergency Service and in the Emergency Department: A Systematic Review. Serra S; Spampinato MD; Riccardi A; Guarino M; Pavasini R; Fabbri A; De Iaco F J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048692 [TBL] [Abstract][Full Text] [Related]
18. Current state of phoenixin-the implications of the pleiotropic peptide in stress and its potential as a therapeutic target. Friedrich T; Stengel A Front Pharmacol; 2023; 14():1076800. PubMed ID: 36860304 [TBL] [Abstract][Full Text] [Related]
19. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex. Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634 [TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Kopp KO; Glotfelty EJ; Li Y; Greig NH Pharmacol Res; 2022 Dec; 186():106550. PubMed ID: 36372278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]